Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATXN7L2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GOLGA8Q | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TRRAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C8orf82 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MTMR7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | STEAP1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | IL17C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PREX2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF496 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |